-->

HTRF VHL-Red Ligand HTRF®

HTRF VHL-Red Ligand is a derivative of VH-032 and can be used as a fluorescent tracer for HTRF VHL-Red Ligand binding assays, associated with the HTRF VHL Binding kit to investigate cooperativity effects within PROTAC drug discovery.

See more
  • Highly specific Highly specific
  • No-wash No-wash
  • Validated with reference Ab Validated with reference Ab

HTRF VHL-Red Ligand is a derivative of VH-032 and can be used as a fluorescent tracer for HTRF VHL-Red Ligand binding assays, associated with the HTRF VHL Binding kit to investigate cooperativity effects within PROTAC drug discovery.

-

Overview

HTRF VHL-Red Ligand is primarily intended to perform affinity binding curves to VHL protein using HTRF® technology.

VHL, also known as von Hippel-Lindau, is involved in many biological processes and is closely associated with the regulation of angiogenesis, cell growth, or cell survival. VHL is one of the most popular E3 ligases recruited by bifunctional Proteolysis-targeting chimeras (PROTACs) to induce ubiquitination and subsequent proteasomal degradation of a targeted protein. VHL interacts with several proteins to form the functional von Hippel-Lindau ubiquitination complex, in which VHL seems to act as a target recruitment subunit in the E3 ubiquitin ligase complex and targets various proteins to proteolysis, such as the hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. 

Identifying new PROTAC VHL ligands can improve selective proteasomal-dependent degradation of proteins of interest involved in the onset of diseases such as cancers.


The HTRF VHL-Red Ligand is primarily intended to perform cooperativity binding studies. It enables calculation of the affinity of the VHL-Red Ligand for VHL protein in the presence of the targeted protein of interest. The determination of the Bmax and the Kd of HTRF VHL-Red Ligand for VHL protein, in absence and presence of the targeted protein, enables the accurate preliminary analysis required for studying cooperative effects assessed with the HTRF Human VHL Binding Kit. 

Benefits

  • EQUILIBRIUM BINDING
  • PHARMACOLOGICAL STUDIES
  • COOPERATIVITY EFFECT

HTRF VHL ligand binding assay principle

HTRF VHL-Red Ligand binding is detected in a direct binding assay format, using an anti 6His-Europium Cryptate antibody which binds to a 6His-tagged Human VHL protein complex. When the dyes are in close proximity, the excitation of the donor with a light source (laser or flash lamp) triggers a Fluorescence Resonance Energy Transfer (FRET) towards the acceptor, which in turn fluoresces at a specific wavelength (665 nm) (Image A). The specific binding signal is calculated by subtracting the non-specific binding signal from the total signal, enabling Kd determination for the HTRF VHL Red Ligand (Image B).

Principle of HTRF VHL-Red ligand binding assays on VHL protein
Principle of HTRF VHL-Red ligand binding assays on VHL protein

HTRF VHL-Red Ligand binding assay protocol

VHL saturation binding experiments of HTRF VHL-Red Ligand can be run in 384-well plates by dispensing 5 µL of Diluent 9 buffer (for Total binding) or VHL Binding standard (for non specific binding). Then 5 µL of PROTAC Binding Buffer 1 (for reference) or the targeted protein diluted in PROTAC Binding Buffer 1 (for cooperativity studies) are added, followed by 5 µL of 6His-tagged VHL protein complex. Finally, 5 µL of a pre-mixed solution of HTRF VHL-Red Ligand and Anti-6His Europium cryptate antibody are added.

The HTRF Ratio is measured after 1 hour of incubation at room temperature.

Assay protocol for HTRF VHL-Red ligand binding assays on VHL protein

​​​​​​​

HTRF VHL-Red Ligand Kd (reference without PROTAC protein substrate)

 24.8 nM +/- 9.7 (2SD)

Determination of the affinity binding (Kd) of VHL-Red Ligand in the presence of targeted protein

In this example, the binding affinity (Kd) of the VHL-Red Ligand to 6His-VHL protein complex was assessed in the absence or presence of the target protein CRBN as example of preliminary cooperativity studies of CRBN/VHL PROTAC compounds. These results indicate that the presence of 65nM of CRBN protein does not change the Kd of the Red Ligand.


Kd determination of HTRF VHL-Red Ligand in cooperativity binding studies

Best practices for pharmacological characterization of PPI inhibitors

Easy pharmacological characterization of PPI modulators. - Technical Notes

HTRF assays handle low- to high affinity protein-protein interactions

Deciphering low- and high affinity interactions - Application Notes

HTRF addresses large protein-protein interaction complexes

Challenge large complexes with HTRF assays - Application Notes

HTRF PPI your dream assay served on a plate

Sandwiches aren't just for eating - Infographics

Virology research solutions using HTRF Protein-Protein Interaction assays

See how peer researchers challenge the viral life cycle with PPI assays - Application Notes

Nuclear receptor ligand identification with HTRF

Monitoring nuclear receptor binding with HTRF assays - Application Notes

A brief history of Protein-Protein Interactions

How well do you know PPI? - Infographics

Batch Information VHL Red Ligand / 20241201

64BDVHLRED Batch 01A - Batch Information

Plate Reader Requirement

Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.

Let's find your reader